CR7060A - PREGABALINE-LACTOSE CONJUGATES - Google Patents

PREGABALINE-LACTOSE CONJUGATES

Info

Publication number
CR7060A
CR7060A CR7060A CR7060A CR7060A CR 7060 A CR7060 A CR 7060A CR 7060 A CR7060 A CR 7060A CR 7060 A CR7060 A CR 7060A CR 7060 A CR7060 A CR 7060A
Authority
CR
Costa Rica
Prior art keywords
lactose
disorders
pregabaline
pregabalin
disorder
Prior art date
Application number
CR7060A
Other languages
Spanish (es)
Inventor
Robert Hurley Timothy
James Lovdahl Michael
Tobias Brian
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to CR7060A priority Critical patent/CR7060A/en
Publication of CR7060A publication Critical patent/CR7060A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporcionan compuestos conjugados de pregabalina-lactosa, tambien se proporciona como parte de la presente invencion un nuevo metodo para tratar en un sujeto trastornos o enfermedades del sistema nervioso central, que incluyen trastornos o crisis convulsivas, dolor, depresion, ansiedad, trastornos del sueno, trastornos consuntivos, psicosis, discinesia tardia, enfermedades de Huntington o Parkinson, administrando al sujeto una cantidad farmaceuticamente eficaz de un conjugado de pregabalina lactosa.Conjugated pregabalin-lactose compounds are provided, a new method for treating a central nervous system disorder or disorder, including seizure disorders or seizures, pain, depression, anxiety, sleep disorders, is also provided as part of the present invention. , consumptive disorders, psychosis, tardive dyskinesia, Huntington's or Parkinson's diseases, administering to the subject a pharmaceutically effective amount of a pregabalin lactose conjugate.

CR7060A 2003-08-26 2003-08-26 PREGABALINE-LACTOSE CONJUGATES CR7060A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR7060A CR7060A (en) 2003-08-26 2003-08-26 PREGABALINE-LACTOSE CONJUGATES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR7060A CR7060A (en) 2003-08-26 2003-08-26 PREGABALINE-LACTOSE CONJUGATES

Publications (1)

Publication Number Publication Date
CR7060A true CR7060A (en) 2004-02-23

Family

ID=44839116

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7060A CR7060A (en) 2003-08-26 2003-08-26 PREGABALINE-LACTOSE CONJUGATES

Country Status (1)

Country Link
CR (1) CR7060A (en)
  • 2003

Similar Documents

Publication Publication Date Title
DOP2002000356A (en) CONJUGADOS DE PREGABALINA LACTOSA
DK1259243T3 (en) Bupropion metabolites, processes for their preparation and their use
CY1122238T1 (en) NOVEL 1-NAPHTHYL-3-AZADICYCLO[3.1.0]HEXANE: PREPARATION AND USE FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS
ES2156162T3 (en) ACTIVE COMPOUNDS IN A NEW SITE ON CALCIUM CHANNELS OPERATED BY A RECEIVER, USEFUL FOR THE TREATMENT OF DISORDERS AND NEUROLOGICAL DISEASES.
HN2001000037A (en) DERIVATIVES OF ETERES DE PIRAZOL AS ANTI-INFLAMMATORY / ANALGESIC AGENTS
BRPI0811956A8 (en) TOPICAL NON-AQUEOUS DICLOFENAC SOLUTION AND PROCESS FOR ITS PREPARATION
MX2010004614A (en) Compositions for treating parkinson's disease.
MX2010009767A (en) Use of mesenchymal stem cells for treating genetic diseases and disorders.
ES2144623T3 (en) DAILY BICYCLE HETERO CYCLES AS CYCLOOXYGENASE-2 INHIBITORS.
NO2012015I2 (en) Dapoxetine
MA31849B1 (en) New pyrimidine derivatives
BRPI0316438B8 (en) erythropoietin use in heart disease
HK1102991A1 (en) Pharmaceutical formulation of decitabine
PA8597301A1 (en) DERIVATIVES OF IMIDAZOL-4-IL-ETINIL-PIRIDINA
EA200300854A1 (en) APPLICATION OF REVERSE AGONISTS OF THE GUMKA IN COMBINATION WITH PARTIAL AGONISTS OF NICOTINE RECEPTORS, ESTROGEN, ELECTORAL MODULATORS OF ESTROGEN OR VITAMIN E FOR TREATMENT OF COGNITIVE RADIATION.
MX2010003603A (en) Method of treating polycystic kidney diseases with ceramide derivatives.
WO2004017904A3 (en) Corticosteroid conjugates and uses thereof
EA201171087A1 (en) METHODS OF ADMINISTRATION (4aR, 10aR) -1-n-PROPIL-1,2,3,4,4a, 5,10,10a-OCTAGHYDROBENZO [g] KHINOLIN-6,7-DIOLA AND RELATED COMPOUNDS THROUGH THE IMMABLE SHELL OF THE CAVITY SLIM OF THE NOSE OR SKIN AND PHARMACEUTICAL COMPOSITIONS ON THEIR BASIS
CR7060A (en) PREGABALINE-LACTOSE CONJUGATES
WO2004092379A3 (en) Method for treatment of angiogenic disorders
DK1641775T3 (en) 2-pyridinal pine derivatives useful for the treatment of pain
BRPI0513395A (en) use of a steroid to increase skin permeability
BR0212607A (en) Replaced urea retinoid agonists ii
UA94044C2 (en) Use of a benzoyl derivative of 3-aminocarbazole for the treatment of disorder associated with e2 prostaglandin production
BR0308753A (en) Method for producing pseudo-islets

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)